已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!

The impact of type 1a endoleak on the long-term outcome after EVAR

医学 外科 血管造影 腔内修复术 计算机断层血管造影 放射科 动脉瘤 主动脉瘤 腹主动脉瘤
作者
Jan Van Slambrouck,Hozan Mufty,Geert Maleux,Sabrina Houthoofd,A. Devooght,Charlotte Slots,Kim Daenens,Inge Fourneau
出处
期刊:Acta Chirurgica Belgica [Taylor & Francis]
卷期号:121 (5): 333-339 被引量:7
标识
DOI:10.1080/00015458.2020.1794337
摘要

Endoleaks remains a major determinant of outcome after endovascular aortic repair (EVAR) for infrarenal abdominal aortic aneurysms. The objective of this study is to evaluate the long-term impact of proximal type 1 endoleak encountered at the case end of the EVAR procedure or during follow-up.All patients treated with EVAR between February 2001 and August 2017 in our institution were included. Data were collected retrospectively. A descriptive analysis of subgroups with type 1a endoleak at case end or with type 1a endoleak first encountered during follow-up was performed.In total, 468 patients were included for analysis. At the case end of the EVAR procedure, in 5.3% (25/468) of patients, a type 1a endoleak was seen. In 72% of cases (18/25) the type 1a endoleak spontaneously disappeared on the first follow-up computed tomography angiography and never recurred. At the end of the follow-up period, no patient in this subgroup died with a type 1a endoleak on follow-up. In 3.4% (16/468) of all cases, a type 1a endoleak was encountered for the first time during follow-up. In 87.5% (14/16) of these cases, reintervention was performed. Two patients died with a persisting type 1a endoleak during follow-up.Clinicians should differentiate between the type 1a endoleak at the case end and the type 1a endoleak first occurring during follow-up. For type 1a endoleak at the case end, expectant management can be adopted. Delayed type 1a endoleak seen during follow-up rarely seals spontaneously and needs reintervention in the majority of cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
张正好发布了新的文献求助10
4秒前
脱壳金蝉完成签到,获得积分10
7秒前
jiyuan发布了新的文献求助10
7秒前
深情安青应助尊敬的灰狼采纳,获得10
7秒前
小蝶完成签到 ,获得积分10
8秒前
15秒前
15秒前
16秒前
宥大冰完成签到,获得积分10
17秒前
18秒前
bkagyin应助jiyuan采纳,获得10
18秒前
19秒前
19秒前
21秒前
XiaoLiu发布了新的文献求助30
21秒前
24秒前
25秒前
25秒前
阳光的衫完成签到,获得积分10
25秒前
卡皮巴拉完成签到,获得积分10
25秒前
25秒前
李海平完成签到 ,获得积分10
26秒前
26秒前
星河之外spectator完成签到,获得积分10
29秒前
shine发布了新的文献求助10
31秒前
32秒前
yarkye完成签到,获得积分10
34秒前
怕黑晓亦完成签到 ,获得积分10
39秒前
42秒前
42秒前
李瑾完成签到,获得积分10
43秒前
gaowei完成签到 ,获得积分10
45秒前
45秒前
csd完成签到,获得积分10
46秒前
折柳完成签到 ,获得积分10
46秒前
李瑾发布了新的文献求助10
46秒前
Jerry完成签到 ,获得积分10
47秒前
xuan发布了新的文献求助10
49秒前
49秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
PowerCascade: A Synthetic Dataset for Cascading Failure Analysis in Power Systems 2000
The Composition and Relative Chronology of Dynasties 16 and 17 in Egypt 1500
Picture this! Including first nations fiction picture books in school library collections 1500
Signals, Systems, and Signal Processing 610
Unlocking Chemical Thinking: Reimagining Chemistry Teaching and Learning 555
Rheumatoid arthritis drugs market analysis North America, Europe, Asia, Rest of world (ROW)-US, UK, Germany, France, China-size and Forecast 2024-2028 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6366574
求助须知:如何正确求助?哪些是违规求助? 8180451
关于积分的说明 17246019
捐赠科研通 5421403
什么是DOI,文献DOI怎么找? 2868450
邀请新用户注册赠送积分活动 1845546
关于科研通互助平台的介绍 1693045